Preventing injuries and violence in communities.
CE24-001, Injury Prevention Research Center at Emory (IPRCE).
This study is looking for ways to help transgender and gender diverse individuals stay safe and reduce injuries, while also making it easier for everyone to access overdose prevention services at pharmacies, especially in communities that need it most.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10765146 on NIH RePORTER |
What this research studies
The Injury Prevention Research Center at Emory (IPRCE) focuses on reducing injuries and violence, particularly among marginalized communities. The research includes developing culturally sensitive screening and intervention strategies for transgender and gender diverse individuals, as well as improving access to overdose prevention services through pharmacies. By identifying barriers and facilitators to effective interventions, the center aims to implement evidence-based practices that can significantly reduce injury rates. The research also emphasizes health equity and community outreach to ensure that vulnerable populations receive the support they need.
Who could benefit from this research
Good fit: Ideal candidates for this research include transgender and gender diverse individuals, as well as those living in communities disproportionately affected by violence and injury.
Not a fit: Patients who do not belong to the targeted marginalized communities or who are not affected by violence or injury may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in injury and violence rates, particularly among historically marginalized communities.
How similar studies have performed: Other research has shown success in implementing community-based interventions for injury prevention, particularly in marginalized populations, indicating that this approach has potential for positive outcomes.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Rupp, Jonathan D. — Emory University
- Study coordinator: Rupp, Jonathan D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.